Law360, New York (September 11, 2012, 1:44 PM EDT) -- A Texas federal judge unsealed a False Claims Act complaint Friday targeting Universal Health Services Inc. and several drugmakers, accusing the of the hospital chain of pocketing drug discounts it received from AstraZeneca PLC, Merck & Co. Inc. and other drugmakers instead of passing the savings on to the government. Two pharmacy directors at UHS-owned hospitals filed the qui tam complaint on behalf of the government, alleging that UHS operated nationwide scheme to leverage any cost-cutting incentives it could get from drugmakers to lower its expenses but never reported those incentives to federal health care programs like Medicare. "The corporate scheme...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

Access to case data within articles (numbers, filings, courts, nature of suit, and more.)

Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.

Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS